Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2018.1536253
Abstract: Abstract Neratinib is a tyrosine kinase inhibitor that was FDA-approved for extended adjuvant treatment in adults with human epidermal growth factor receptors-2 (HER-2) positive breast cancer in 2017. Due to the novelty of the drug,…
read more here.
Keywords:
effects neratinib;
dermatology;
adverse cutaneous;
acneiform ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Psychiatry and Clinical Psychopharmacology"
DOI: 10.1080/24750573.2018.1464633
Abstract: ABSTRACT Acneiform is used to describe eruptions that resemble acne vulgaris, but are not aetiologically similar. A number of drugs that can be responsible for acneiform eruptions exist. Vortioxetine is a multimodal antidepressant molecule that…
read more here.
Keywords:
vortioxetine;
acneiform eruption;
eruption associated;
associated use ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Clinical and experimental dermatology"
DOI: 10.1093/ced/llad124
Abstract: Chloracne is an extremely rare acneiform eruption triggered by exposure to chemicals containing halogenated aromatic hydrocarbons. Unlike acne, which tends to affect areas with a high concentration of sebaceous glands, the most common areas affected…
read more here.
Keywords:
bilateral periocular;
acneiform;
chloracne;
periocular acneiform ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Dermatologic Therapy"
DOI: 10.1111/dth.14893
Abstract: Dear Editor, Follicular mucinosis (FM) is a rare inflammatory condition with external root sheath mucin deposition. FM typically occurs as a primary benign idiopathic disorder manifesting with follicular papules and indurated plaques. FM variants include…
read more here.
Keywords:
follicular mucinosis;
narrowband uvb;
lesional narrowband;
oral dapsone ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Dermatologic therapy"
DOI: 10.1111/dth.15412
Abstract: Epidermal growth factor receptor inhibitors (EGFRi) are now standard of care in patients with EGFR mutations in non-small cell lung cancer (NSCLC) and are increasingly being used in other EGFR mutated cancers, including gastrointestinal, and…
read more here.
Keywords:
acneiform;
review;
epidermal growth;
acneiform eruptions ... See more keywords